483 research outputs found
Spin- and time-resolved photoemission studies of thin Co2FeSi Heusler alloy films
We have studied the possibly half metallic Co2FeSi full Heusler alloy by
means of spin- and time-resolved photoemission spectroscopy. For excitation,
the second and fourth harmonic of femtosecond Ti:sapphire lasers were used,
with photon energies of 3.1 eV and 5.9 eV, respectively. We compare the
dependence of the measured surface spin polarization on the particular
photoemission mechanism, i.e. 1-photon-photoemission (1PPE) or 2-photon
photoemission (2PPE). The observed differences in the spin polarization can be
explained by a spin-dependent lifetime effect occurring in the 2-photon
absorption process. The difference in escape depth of the two methods in this
context suggests that the observed reduction of spin polarization (compared to
the bulk) cannot be attributed just to the outermost surface layer but takes
place at least 4-6 nm away from the surface.Comment: 7 pages, 3 figures; submitted to Journal of Magnetism and Magnetic
Material
Anti-transglutaminase 6 antibodies in children and young adults with cerebral palsy.
Objectives. We have previously reported a high prevalence of gluten-related serological markers (GRSM) in children and young adults with cerebral palsy (CP). The majority had no enteropathy to suggest coeliac disease (CD). Antibodies against transglutaminase 6 (anti-TG6) represent a new marker associated with gluten-related neurological dysfunction. The aim of this study was to investigate the prevalence of anti-TG6 antibodies in this group of individuals with an early neurological injury resulting in CP. Materials and Methods. Sera from 96 patients with CP and 36 controls were analysed for IgA/IgG class anti-TG6 by ELISA. Results. Anti-TG6 antibodies were found in 12/96 (13%) of patients with CP compared to 2/36 (6%) in controls. The tetraplegic subgroup of CP had a significantly higher prevalence of anti-TG6 antibodies 6/17 (35%) compared to the other subgroups and controls. There was no correlation of anti-TG6 autoantibodies with seropositivity to food proteins including gliadin. Conclusions. An early brain insult and associated inflammation may predispose to future development of TG6 autoimmunity
TG6 auto-antibodies in dermatitis herpetiformis
Dermatitis herpetiformis (DH) is an extraintestinal manifestation of gluten sensitivity, in which an autoimmune response is directed against transglutaminase 3 (TG3), an epidermal transglutaminase. TG2 is the autoantigen in celiac disease (CD), defined by the presence of enteropathy, and TG6 is the autoantigen in neurological manifestations of gluten sensitivity. The interplay between B cell responses to these 3 transglutaminases in developing the clinical spectrum of disease manifestations is not completely understood. Also, the individual or combined diagnostic and predictive value of the respective autoantibodies is not fully explored. We examined the prevalence of TG6 antibodies in a cohort of patients with DH. TG6 positivity was found in 13/33 (39%), with IgA detected in 11 patients, IgG in 3, and both in 1. This was significantly higher compared to what is seen in the classic CD cases (14%) in a Finnish population. TG6 positive baseline samples constituted 60% of DH patients with no enteropathy (n = 10), as opposed to 17% positivity in those with overt enteropathy (n = 12; Marsh IIIB). Repeat testing after adherence to a gluten-free diet for 1 year showed reduced titers for TG6 antibodies in 11/13 (85%), whereby 7 patients were now TG6 antibody-negative. Four patients seroconverted and tested positive for TG6 antibodies at one year, due to the ongoing exposure to gluten. We report another patient who presented with neurological manifestations (encephalopathy) leading to the diagnosis of CD, who was intermittently adhering to a gluten-free diet. Serological testing at baseline showed him to be positive for antibodies to all 3 transglutaminases. Eleven years later, he developed DH. He also subsequently developed ataxia and peripheral neuropathy. Although TG3 and TG6 autoantibodies are linked to certain disease manifestations, TG2, TG3, and TG6 autoantibodies can be present across the spectrum of GRD patients and might develop years before onset of symptoms of extraintestinal manifestations. This is consistent with gluten-dependent adaptive immunity being a necessary but not sufficient pretext to organ-specific damage. TG6 antibodies appear to develop more frequently in patients where tolerance to gluten was broken but, either there was no development of the molecular state driving the tissue destruction at the level of the gut, or perhaps more likely, there was more resistance to developing this phenotype
Experimental time-resolved photoemission and ab initio study of lifetimes of excited electrons in Mo and Rh
We have studied the relaxation dynamics of optically excited electrons in
molybdenum and rhodium by means of time resolved two-photon photoemission
spectroscopy (TR-2PPE) and ab initio electron self-energy calculations
performed within the GW and GW+T approximations. Both theoretical approaches
reproduce qualitatively the experimentally observed trends and differences in
the lifetimes of excited electrons in molybdenum and rhodium. For excitation
energies exceeding the Fermi energy by more than 1 eV, the GW+T theory yields
lifetimes in quantitative agreement with the experimental results. As one of
the relevant mechanisms causing different excited state lifetime in Mo and Rh
we identify the occupation of the 4d bands. An increasing occupation of the 4d
bands results in an efficient decrease of the lifetime even for rather small
excitation energies of a few 100 meV.Comment: 8 pages, 10 figure
Love kills: Simulations in Penna Ageing Model
The standard Penna ageing model with sexual reproduction is enlarged by
adding additional bit-strings for love: Marriage happens only if the male love
strings are sufficiently different from the female ones. We simulate at what
level of required difference the population dies out.Comment: 14 pages, including numerous figure
Neurological Dysfunction in Coeliac Disease and Non-Coeliac Gluten Sensitivity
OBJECTIVES: Non-coeliac gluten sensitivity (NCGS) refers to patients with primarily gastrointestinal symptoms
without enteropathy that symptomatically benefi t from gluten-free diet (GFD). Little is known about
its pathophysiology, propensity to neurological manifestations, and if these differ from patients with
coeliac disease (CD). We investigated the clinical and immunological characteristics of patients
presenting with neurological manifestations with CD and those with NCGS.
METHODS: We compared clinical, neurophysiological, and imaging data of patients with CD and NCGS
presenting with neurological dysfunction assessed and followed up regularly over a period of
20 years.
RESULTS: Out of 700 patients, 562 were included. Exclusion criteria included no bowel biopsy to confi rm
CD, no HLA type available, and failure to adhere to GFD. All patients presented with neurological
dysfunction and had circulating anti-gliadin antibodies. Out of 562 patients, 228 (41%) had
evidence of enteropathy (Group 1, CD) and 334 (59%) did not (Group 2, NCGS). The most common
neurological manifestations were cerebellar ataxia, peripheral neuropathy, and encephalopathy. There
was a greater proportion of patients with encephalopathy in Group 1 and with a greater proportion
of neuropathy in Group 2. The severity of ataxia did not differ between the two groups. Patients in
Group 1 had more severe neuropathy. All patients from both groups responded to gluten-free diet.
Anti-tissue transglutaminase (TG2) antibodies were found in 91% of patients in Group 1 and in
29% of patients in Group 2. Comparison between those patients in Group 2 with HLA-DQ2/DQ8 and
those without as well as those with positive TG2 compared with those with negative TG2 antibodies
identifi ed no differences within these subgroups. Serological positivity for TG6 antibodies was similar
in the two groups (67 and 60%).
CONCLUSIONS: The neurological manifestations of CD and NCGS are similar and equally responsive to a GFD
suggestive of common pathophysiological mechanisms
Neurologic deficits in patients with newly diagnosed celiac disease are frequent and linked with autoimmunity to TG6
Background & Aims
Celiac disease is an autoimmune disorder induced by ingestion of gluten that affects 1% of the population and is characterized by gastrointestinal symptoms, weight loss, and anemia. We evaluated the presence of neurologic deficits and investigated whether the presence of antibodies to TG6 increases the risk of neurologic defects in patients with a new diagnosis of celiac disease.
Methods
We performed a prospective cohort study at a secondary-care gastroenterology center of 100 consecutive patients who received a new diagnosis of celiac disease based on gastroscopy and duodenal biopsy. We collected data on neurologic history, and patients were evaluated in a clinical examination along with magnetic resonance imaging (MRI) of the brain, MR spectroscopy of the cerebellum, and measurements of antibodies against TG6 in serum samples. The first 52 patients recruited underwent repeat MR spectroscopy at 1 year after a gluten-free diet (GFD). The primary aim was to establish if detection of antibodies against TG6 can be used to identify patients with celiac disease and neurologic dysfunction.
Results
Gait instability was reported in 24% of the patients, persisting sensory symptoms in 12%, and frequent headaches in 42%. Gait ataxia was found in 29% of patients, nystagmus in 11%, and distal sensory loss in 10%. Sixty percent of patients had abnormal results from the MRI, 47% had abnormal results from MR spectroscopy of the cerebellum, and 25% had brain white matter lesions beyond that expected for their age group. Antibodies against TG6 were detected in serum samples from 40% of patients–these patients had significant atrophy of subcortical brain regions compared to patients without TG6 autoantibodies. In patients with abnormal results from MR spectroscopy of the cerebellum, those on the GFD had improvements detected in the repeat MR spectroscopy 1 year later.
Conclusions
In a prospective cohort study of patients with a new diagnosis of celiac disease at a gastroenterology clinic, neurological deficits were common and 40% had circulating antibodies against TG6. We observed a significant reduction in volume of specific brain regions in patients with TG6 autoantibodies, providing evidence for a link between autoimmunity to TG6 and brain atrophy in patients with celiac disease. There is a need for early diagnosis, increased awareness of the neurological manifestations amongst clinicians and reinforcement of adherence to a strict GFD by patients in order to avoid permanent neurological disability
- …